Galecto, Inc.(GLTO)
Biotech company identified as a reverse merger
1 Insight
Investment Insights
AI-generated insights about Galecto, Inc. from various financial sources
Monday, November 10, 2025
Very Bearish
Target: $10 or less
The speaker views it as a "good short" that should trade back down to $10 or less, but notes that it is "not easy to borrow shares."
Monday, November 10, 2025
Very Bearish
Target: $10 or less
The speaker views it as a "good short" that should trade back down to $10 or less, but notes that it is "not easy to borrow shares."